Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity

Surg Obes Relat Dis. Nov-Dec 2008;4(6):748-53. doi: 10.1016/j.soard.2008.03.005. Epub 2008 Jun 30.

Abstract

Background: Confusion exists when dosing heparin using a weight-based nomogram in the obese population. At 2 affiliated community teaching hospitals, we compared the activated partial thromboplastin time (aPTT) values in morbidly obese and nonmorbidly obese patients using a standardized nomogram and determined factors associated with achieving a supratherapeutic aPTT value.

Methods: This was a retrospective study that included patients who had received intravenous heparin according to a standardized weight-based nomogram for >or=12 hours. The exclusion criteria were age <18 years, pregnancy, and insufficient data. Patients were stratified into morbidly obese (body mass index [BMI] >or=40 kg/m(2)) and nonmorbidly obese (BMI <40 kg/m(2)) groups. The aPTT values were compared and predictors for a supratherapeutic aPTT values were identified.

Results: A total of 101 patients were included in the study. Greater aPTT values were noted at 6 hours (155 +/- 37 versus 135 +/- 44, P = .020) and 12 hours (141 +/- 45 versus 117 +/- 45, P = .012) for patients with morbid obesity than for those without it, respectively. Increasing BMI (odds ratio = 1.06, 95% confidence interval 1.02-1.1; P = .003) and age (odds ratio 1.05, 95% confidence interval 1.02-.09; P = .001] were independent predictors of supratherapeutic aPTT values.

Conclusion: Heparin dosing with a weight-based nomogram will yield greater aPTT values in morbidly obese patients. Consideration of BMI and age can help identify those patients at risk of supratherapeutic aPTTs. Alternative strategies, such as a dose cap should be considered in patients with morbid obesity.

MeSH terms

  • Analysis of Variance
  • Anticoagulants / administration & dosage*
  • Body Weight
  • Chi-Square Distribution
  • Heparin / administration & dosage*
  • Humans
  • Nomograms*
  • Obesity, Morbid
  • Partial Thromboplastin Time
  • Retrospective Studies
  • Statistics, Nonparametric

Substances

  • Anticoagulants
  • Heparin